Man Shang
Impact in
-
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- Medicinal Plant Pharmacodynamics Research
Papers in
-
- Extracellular vesicles in disease 7
-
- MicroRNA in disease regulation 2
- Co-authors
- Ting Wang (4 shared papers)Qiujing Yu (3 shared papers)Aifeng Liu (5 shared papers)Jun-Qiu Song (6 shared papers)Ming‐Lin Liu (6 shared papers)Yuan Fu (2 shared papers)Huijie Yang (1 shared paper)Jinfa Gu (1 shared paper)
- Journals
- Nature Communications (2 papers)Frontiers in Pharmacology (2 papers)BMC Complementary Medicine and Therapies (1 paper)BMC Complementary and Alternative Medicine (1 paper)Cell Reports (1 paper)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Man Shang
20 papers receiving 367 citations
Peers
Comparison fields: 5 of 73
- Cancer Research 103
- Pharmacology 38
- Immunology 79
- Molecular Biology 230
- Rheumatology 38
Countries citing papers authored by Man Shang
This map shows the geographic impact of Man Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Man Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Man Shang more than expected).
Fields of papers citing papers by Man Shang
This network shows the impact of papers produced by Man Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Man Shang. The network helps show where Man Shang may publish in the future.
Co-authors
The 25 scholars most cited alongside Man Shang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 114 | |
| 2 | 2016 | 49 | |
| 3 | 2022 | 31 | |
| 4 | 2018 | 30 | |
| 5 | 2020 | 24 | |
| 6 | 2023 | 18 | |
| 7 | 2019 | 17 | |
| 8 | 2021 | 13 | |
| 9 | 2020 | 13 | |
| 10 | New aristolochic acid, aristololactam and renal cytotoxic constituents from the stem and leaves of Aristolochia contorta. | 2005 | 12 |
| 11 | 2021 | 9 | |
| 12 | 2024 | 9 | |
| 13 | 2017 | 9 | |
| 14 | Flow cytometric analysis of circulating microvesicles derived from myocardial Ischemic preconditioning and cardioprotection of Ischemia/reperfusion Injury in rats. | 2015 | 6 |
| 15 | 2023 | 5 | |
| 16 | 2024 | 4 | |
| 17 | Microvesicles derived from hypoxia/reoxygenation-treated human umbilical vein endothelial cells impair relaxation of rat thoracic aortic rings. | 2014 | 4 |
| 18 | Effects of endothelial microvesicles induced by A23187 on H9c2 cardiomyocytes. | 2013 | 2 |
| 19 | Detection of HPV-16 DNA in cervical carcinoma by paraffin section in situ hybridization. | 1990 | 1 |
| 20 | 2016 | 1 |
About Man Shang
Man Shang is a scholar working on Molecular Biology, Cancer Research, Oncology, Pharmacology and Immunology, having authored 20 papers that have together received 371 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (7 papers), Osteoarthritis Treatment and Mechanisms (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Medicinal Plant Pharmacodynamics Research (3 papers), MicroRNA in disease regulation (2 papers), Cardiovascular Disease and Adiposity (2 papers), Lower Extremity Biomechanics and Pathologies (2 papers) and Knee injuries and reconstruction techniques (2 papers). The work is most often cited by research in Cancer Research (103 citations), Pharmacology (38 citations), Immunology (79 citations), Molecular Biology (230 citations) and Rheumatology (38 citations). Man Shang has collaborated with scholars based in China, United States and India. Frequent co-authors include Ting Wang, Qiujing Yu, Aifeng Liu, Jun-Qiu Song, Ming‐Lin Liu, Yuan Fu, Huijie Yang, Jinfa Gu, Juntao Zhang and Xinyuan Liu. Their work appears in journals such as Nature Communications, Frontiers in Pharmacology, BMC Complementary Medicine and Therapies, BMC Complementary and Alternative Medicine and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.